The Auscann Group Holdings Ltd (ASX: AC8) share price has continued its strong run and is up a further 6% to 46 cents today.
This means the medicinal cannabis company's shares have jumped over 20% since this time last week.
Why has it jumped?
The rally in AusCann's shares can be traced back to June 15 when the company announced the key appointment of Dr Danial Schecter as Chief Medical Advisor.
Since the day of this announcement, AusCann's shares have climbed in excess of 30%.
Investors appear to be optimistic that the appointment of the international medical cannabis expert will help the company succeed in its medical outreach program.
The company aims for the program to educate Australian physicians about the benefits of medicinal cannabis, ultimately allowing them to make an informed decision on whether or how to prescribe cannabinoid medicines.
